James Taylor is the Co-Founder of Precision NanoSystems Inc., a global leader in technologies and solutions for development of genetic medicines. He holds a B.A.Sc. in engineering physics from the University of British Columbia and a Ph.D. in genetics from the Institute for Systems Biology in Seattle, Washington. James worked at the Seattle-based venture capital firm, Accelerator Corporation, concurrent with his Ph.D., Centre for Drug Research and Development in Vancouver, British Columbia, and has extensive experience in the science and commercialization of microfluidics, nanotechnology and systems biology. He has been the leader of Precision NanoSystem’s technology and commercialization since invention, the company offering proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genetic medicines.
11:00 AM - 12:00 PM (PDT)
Tuesday, June 14
Genomic medicines continues to move to the forefront with an expected growth to $95B in 2028 (from …